Mesoblast Ltd ADR (MESO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MESO | RARE | DNTH | ||
| Company | Mesoblast Ltd ADR | Ultragenyx Pharmaceu | Dianthus Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.89 | 21.56 | 49.21 | ||
| High | 16.98 | 22.87 | 50.69 | ||
| Low | 16.70 | 21.31 | 47.79 | ||
| Latest | 16.88 | 22.72 | 49.56 | ||
| Change | -0.03 | +0.89 | -0.16 | ||
| % Change | -0.18% | +4.08% | -0.32% | ||
| Volume | 168,400 | 2,130,100 | 388,400 | ||
| 20-Day Average Volume | 184,030 | 2,496,655 | 730,330 | ||
| Previous Close | 16.91 | 21.83 | 49.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.40 | 23.49 | 50.32 | ||
| 20-Day Raw Stochastic | 35.09% | 50.12% | 33.05% | ||
| 20-Day Relative Strength | 46.45 | 43.23 | 54.31 | ||
| Weighted Alpha | -3.00 | -33.99 | +104.16 | ||
| Today's Opinion | 24% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 24% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.06% since 02/12/26 | -3.32% since 02/12/26 | +4.38% since 02/12/26 | ||
| Low | 16.50 on 02/13/26 | 19.60 on 02/13/26 | 46.80 on 02/19/26 | ||
| High | 17.30 on 02/18/26 | 23.17 on 02/13/26 | 50.69 on 02/20/26 | ||
| 1-Month | |||||
| %Chg | +0.30% since 01/20/26 | +0.40% since 01/20/26 | +6.35% since 01/20/26 | ||
| Low | 15.55 on 02/06/26 | 19.60 on 02/13/26 | 45.64 on 02/12/26 | ||
| High | 19.34 on 01/27/26 | 25.82 on 02/03/26 | 57.50 on 01/30/26 | ||
| 3-Month | |||||
| %Chg | +17.88% since 11/20/25 | -27.13% since 11/20/25 | +22.70% since 11/20/25 | ||
| Low | 14.69 on 11/21/25 | 18.41 on 12/29/25 | 35.84 on 01/06/26 | ||
| High | 21.50 on 01/09/26 | 39.89 on 12/08/25 | 57.50 on 01/30/26 | ||
| 6-Month | |||||
| %Chg | +12.46% since 08/20/25 | -22.62% since 08/20/25 | +111.61% since 08/20/25 | ||
| Low | 12.66 on 09/03/25 | 18.41 on 12/29/25 | 22.76 on 08/22/25 | ||
| High | 21.50 on 01/09/26 | 39.89 on 12/08/25 | 57.50 on 01/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,178,026 | 2,195,433 | 2,142,132 | ||
| Shares Outstanding, K | 129,030 | 96,630 | 43,223 | ||
| Annual Sales | 17,200,000 | 673,000,000 | 6,240,000 | ||
| Annual Net Income | -102,140,000 | -575,000,000 | -84,970,000 | ||
| Last Quarter Sales | 1,930,000 | 207,000,000 | 400,000 | ||
| Last Quarter Net Income | -21,920,000 | -129,000,000 | -36,770,000 | ||
| 60-Month Beta | 2.15 | 0.16 | 1.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/06/19 | -1.29 on 02/12/26 | -0.97 on 11/05/25 | ||
| Latest Earnings Date | 02/26/26 | 05/05/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||